Abstract
Chlamydia pneumoniae is an obligate intracellular bacterium which is difficult to diagnose by conventional means. Concerning serology, several problems are involved such as non-standardization of reagents and the technical complexity of the assay. Culture of the organism in tissue culture is the current gold standard to demonstrate that a patient is infected by viable C. pneumoniae, but the use of culture for detection of C. pneumoniae is problematic because of low sensitivity. Since C. pneumoniae can cause severe clinical disease, correct diagnosis and therapy are important. Faster, more sensitive and less laborious methods are therefore required. The ability of the polymerase chain reaction (PCR) technique to rapidly amplify small amounts of specific nucleic acid has made this technique an important diagnostic tool with potential to offer clinical laboratories a convenient means to detect C. pneumoniae rapidly and reliably. Although significant improvements have been made in developing molecular methods for the detection of C. pneumoniae, several problems remain. For example, a variety of different PCR-based assays have been developed, and one important issue is comparison of methods and standardization of the protocols. Nevertheless, increased use of automation and the introduction of commercial diagnostic kits will improve standardization and availability. Furthermore, use of new molecular techniques, such as quantitative PCR and sequence analysis, will promote research applications and improve the effectiveness for diagnosis of C. pneumoniae.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ieven M, Goossens H (1997) Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory. Clin Microbiol Rev 10: 242–256
Palmer HM (1994) The chlamydiales and mycoplasmatales. In: Ehrlich GD, Greenberg SJ (eds) PCR-based diagnostics in infectious diseases. Blackwell, Boston, pp 493–510
Martin GP, Timmers E (1997) PCR and its modifications for the detection of infectious diseases. In: Lee HH, Morse SA, Olsvik O (eds) Nucleic acid amplification technologies: application to disease diagnosis. BioTechniques, Eaton, Cambridge, Mass, pp 79–99
Wilson IG (1997) Inhibition and facilitation of nucleic acid amplification. Appl Environ Microbiol 63: 3741–3751
Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS (1991) “Touchdown” PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 19: 4008
Tong CYW, Sillis M (1993) Detection of Chlamydia pneumoniae and Chlamydia psittaciin sputum samples by PCR. J Clin Pathol 46: 313–317
Boman J, Allard A, Persson K, Lundborg M, Juto P, Wadell G (1997) Rapid diagnosis of respiratory Chlamydia pneumoniae infection by nested touchdown polymerase chain reaction compared with culture and antigen detection by EIA. J Infect Dis 75: 1523–1526
Black CM, Fields PI, Messmer TO, Berdal BP (1994) Detection of Chlamydia pneumoniae in clinical specimens by polymerase chain reaction using nested primers. Eur J Clin Microbiol Infect Dis 13: 752–756
Verkooyen RP, Willemse D, Casteren SC, Joulandan SA, Snijder RJ, van denBosch JM, van Helden HP, Peeters MF, Verbrugh HA (1998) Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections. J Clin Microbiol 36: 2301–2307
Hammerschlag MR, Chirgwin K, Roblin PM, Gelling M, Dumornay W, Mandel L, Smith P, Schachter J (1998) Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 14: 178–182
Khan MA, Potter CW, Sharrard RM (1996) A reverse transcriptase-PCR based assay for in-vitro antibiotic susceptibility testing of Chlamydia pneumoniae. J Antimicrob Chemother 37: 677–685
Whelen AC, Persing DH (1996) The role of nucleic acid amplification and detection in the clinical microbiology laboratory. Annu Rev Microbiol 50: 349–373
Kwok S, Higuchi R (1989) Avoiding false positives with PCR. Nature 339: 237–238
Kwok S (1990) Procedures to minimize PCR-product carry-over. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds) PCR protocols — A guide to methods and applications. Academic Press, San Diego, pp 142–145
Boman J, Soderberg S, Forsberg J, Birgander LS, Allard A, Persson K, Jidell E, Kumlin U, Juto P, Waidenstrom A, Wadell G (1998) High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis 178: 274–277
Jantos CA, Roggendorf R, Wuppermann FN, Hegemann JH (1998) Rapid detection of Chlamydia pneumoniae by PCR-enzyme immunoassay. J Clin Microbiol 36: 1890–1894
Pham DG, Madico GE, Quinn TC, Enzler MJ, Smith TF, Gaydos CA (1998) Use of lambda phage DNA as a hybrid internal control in a PCR-enzyme immunoassay to detect Chlamydia pneumoniae. J Clin Microbiol 36: 1919–1922
Andersen AB, Thybo S, Godfrey-Faussett P, Stoker NG (1993) Polymerase chain reaction for detection of Mycobacterium tuberculosis in sputum. Eur J Clin Microbiol Infect Dis 12: 922–927
Dalhoff K, Maass M (1996) Chlamydia pneumoniae pneumonia in hospitalized patients. Clinical characteristics and diagnostic value of polymerase chain reaction detection in BAL. Chest 110: 351–356
Pruckl PM, Aspock C, Makristathis A, Rotter ML, Wank H, Willinger B, Hirschl AM (1995) Polymerase chain reaction for detection of Chlamydia pneumoniae in gargled-water specimens of children. Eur J Clin Microbiol Infect Dis 14: 141–144
Kuo C-C, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT (1993) Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 167: 841–849
Naidu BR, Ngeow Y-F, Pang T (1997) MOMP-based PCR reveals presence of Chlamydia pneumoniae DNA in respiratory and serum samples of patients with acute C. pneumoniae-associated infections. J Microbiol Methods 28: 1–9
Naidu BR, Ngeow Y-F, Kannan P, Jeyamalar R, Khir A, Khoo KL, Pang T (1997) Evidence of Chlamydia pneumoniae infection obtained by the polymerase chain reaction (PCR) in patients with acute myocardial infarction and coronary heart disease. J Infect 35: 199–200
Wadowsky RM, Laus S, Libert T, States SJ, Ehrlich GD (1994) Inhibition of PCR-based assay for Bordetella pertussis by using calcium alginate fiber and aluminium shaft components of a nasopharyngeal swab. J Clin Microbiol 32: 1054–1057
Black CM, Tharpe JA, Russell H (1992) Distinguishing Chlamydia species by restriction analysis of the major outer membrane protein gene. Mol Cell Probes 6: 395–400
O’Leary JJ, Engels K, Dada MA (1997) The polymerase chain reaction in pathology. J Clin Pathol 50: 805–810
Gnarpe J, Eriksson K (1995) Sample preparation for Chlamydia pneumoniae PCR. APMIS 103: 307–308
Daugharty H, Skelton SK, Messmer T (1998) Chlamydia DNA extraction for use in PCR: stability and sensitivity in detection. J Clin Lab Anal 12: 47–53
Maass M, Dalhoff K (1994) Comparison of sample preparation methods for detection of Chlamydia pneumoniae in bronchoalveolar lavage fluid by PCR. J Clin Microbiol 32: 2616–2619
Wilson PA, Phipps J, Samuel D, Saunders NA (1996) Development of a simplified polymerase chain reaction-enzyme immunoassay for the detection of Chlamydia pneumoniae. J Appl Bacteriol 80: 431–438
Sillis M, White P, Caul EO, Paul ID, Treharne JD (1992) The differentiation of Chlamydia species by antigen detection in sputum specimens from patients with community-acquired acute respiratory infections. J Infect 25[Suppl l]: 77–86
Gaydos CA, Quinn TC, Eiden JJ (1992) Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene. J Clin Microbiol 30: 796–800
Gaydos CA, Roblin PM, Hammerschlag MR, Hyman CL, Eiden JJ, Schachter J, Quinn TC (1994) Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients. J Clin Microbiol 32: 903–905
Gaydos CA, Fowler CL, Gill VJ, Eiden JJ, Quinn TC (1993) Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in an immunocompromised population. Clin Infect Dis 17: 718–723
Gaydos CA, Eiden JJ, Oldach D, Mundy LM, Auwaerter P, Warner ML, Vance E, Burton AA, Quinn TC (1994) Diagnosis of Chlamydia pneumoniae infection in patients with community-acquired pneumonia by polymerase chain reaction enzyme immunoassay. Clin Infect Dis 19: 157–160
Campbell LA, Perez Melgosa M, Hamilton DJ, Kuo C-C, Grayston JT (1992) Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol 30: 434–439
Khan MA, Potter CW (1996) The nPCR detection of Chlamydia pneumoniae and Chlamydia trachomatis in children hospitalized for bronchiolitis. J Infect 33: 173–175
Schmidt BL (1997) PCR in laboratory diagnosis of human Borrelia burgdorferi infection. Clin Microbiol Rev 10: 185–201
Grayston JT, Aldous MB, Easton A, Wang SP, Kuo C-C, Campbell LA, Altman J (1993) Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis 168: 1231–1235
Hammerschlag MR (1995) Diagnostic methods for intracellular pathogens. Clin Microbiol Infect 1[Suppl 1]: S3–S8
Hyman CL, Roblin PM, Gaydos CA, Quinn TC, Schachter J, Hammerschlag MR (1995) Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis 20: 1174–1178
Maass M, Bartels C, Engel PM, Mamat U, Sievers HH (1998) Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 31: 827–832
Campbell LA, O’Brien ER, Cappuccio AL, Kuo C-C, Wang S-P, Stewart D, Patton DL, Cummings PK, Grayston JT (1995) Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 172: 585–588
Juvonen J, Juvonen T, Laurila A, Alakarppa H, Lounatmaa K, Surcel HM, Leinonen M, Kairaluoma MI, Saikku P (1997) Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg 25: 499–505
Lindholt JS, Ostergard L, Henneberg EW, Fasting H, Andersen P (1998) Failure to demonstrate Chlamydia pneumoniae in symptomatic abdominal aortic aneurysms by a nested polymerase chain reaction (PCR). Eur J Vasc Endovasc Surg 15: 161–164
Weiss SM, Roblin PM, Gaydos CA, Cummings P, Patton DL, Schulhoff N, Shani J, Frankel R, Penney K, Quinn TC, Hammerschlag MR, Schachter J (1996) Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 173: 957–962
Ong G, Thomas BJ, Mansfield AO, Davidson BR, Taylor-Robinson D (1996) Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 49: 102–106
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Italia, Milano
About this chapter
Cite this chapter
Boman, J., Gaydos, C.A. (1999). Chlamydia pneumoniae: Molecular Biology Methods. In: Allegra, L., Blasi, F. (eds) Chlamydia pneumoniae. Springer, Milano. https://doi.org/10.1007/978-88-470-2280-5_4
Download citation
DOI: https://doi.org/10.1007/978-88-470-2280-5_4
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0047-6
Online ISBN: 978-88-470-2280-5
eBook Packages: Springer Book Archive